Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
BMJ Quality & Safety|March 23, 2012
Using quality improvement to accelerate highly active antiretroviral treatment coverage in South AfricaPatty D Webster, Maria Sibanyoni, Dinah Malekutu, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
HIV Viral Load Testing in the South African Public Health Setting in the Context of Evolving ART Guidelines and Advances in Technology, 2013-2022Lucia Hans, Naseem Cassim, Somayya Sarang, et al.
AIDS (London, England)|July 14, 2021
The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenzSumbul Asif, Evangelia Baxevanidi, Andrew Hill, et al.
AIDS (London, England)|July 11, 2003
Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapineLynn Morris, Candice Pillay, Claudia Chezzi, et al.
AIDS and Behavior|November 27, 2022
Slow and Steady But Not Related to HIV Stigma: Physical Activity in South Africans Living with HIV and Chronic PainAntonia Wadley, Peter Kamerman, Tamar Pincus, et al.
International Journal of STD & AIDS|May 12, 2018
CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values?Willem Daniel Francois Venter, Matthew F Chersich, Mohammed Majam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2018
Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological OutcomesMichelle Moorhouse, Gary Maartens, Willem Daniel Francois Venter, et al.
Plos One|December 3, 2020
Working nights and lower leisure-time physical activity associate with chronic pain in Southern African long-distance truck drivers: A cross-sectional studyAntonia L Wadley, Stella Iacovides, Johanna Roche, et al.
AIDS Care|September 15, 2006
Effect of antiretroviral treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South AfricaS Skogmar, D Shakely, M Lans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2022
Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTGBronwyn Bosch, Godspower Akpomiemie, Nomathemba Chandiwana, et al.
Pageof 15